The effect of cinnamon extract on insulin resistance parameters in polycystic ovary syndrome: a pilot study

Fertility and Sterility

Volumn 88, Issue 1, 2007, Pages 240-243

  Wang, Jeff G ^a   Anderson, Richard A ^b   Graham III, George M ^c   Chu, Micheline C ^a   Sauer, Mark V ^a   Guarnaccia, Michael M ^a   Lobo, Rogerio A ^a  

^a College of Physicians and Surgeons ^*  (United States)

^b BELTSVILLE HUMAN NUTRITION RESEARCH CENTER   (United States)

^c UNIVERSITY OF HAWAII   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CINNAMON EXTRACT; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL;

ADULT; CINNAMOMUM ZEYLANICUM; FEMALE; HUMANS; INSULIN RESISTANCE; PILOT PROJECTS; PLANT EXTRACTS; POLYCYSTIC OVARY SYNDROME;

EID: 34347206834     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2006.11.082     Document Type: Article

References (24)

1. Franks S. Polycystic ovary syndrome. N Engl J Med 333 (1995) 853-861
2. Rotterdam. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). ROTTERDAM ESHRE ASRM-sponsored PCOS consensus workshop group (2004) Rotterdam 41-7
3. Rotterdam. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). ROTTERDAM ESHRE ASRM-sponsored PCOS consensus workshop group (2004) 19-25 Rotterdam
4. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocrinol Rev 18 (1997) 774-800
5. Carmina E., and Lobo R.A. Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome. Fertil Steril 82 (2004) 661-665
6. Nestler J.E., Jakubowicz D.J., de Vargas A.F., Brik C., Quintero N., and Medina F. Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J Clin Endocrinol Metab 83 (1998) 2001-2005
7. Azziz R. Androgen excess is the key element in polycystic ovary syndrome. Fertil Steril 80 (2003) 252-254
8. Legro R.S., Myers E.R., Schlaff W.D., Carr B.R., and Diamond M.P. Improvement in live births with clomiphene citrate and metformin, alone and in combination, in infertile women with polycystic ovary syndrome. Fertil Steril 86 (2006) S1
9. Lord J.M., Flight I.H., and Norman R.J. Metformin in polycystic ovary syndrome: systematic review and meta-analysis. BMJ 327 (2003) 951-953
10. Haas D.A., Carr B.R., and Attia G.R. Effects of metformin on body mass index, menstrual cyclicity, and ovulation induction in women with polycystic ovary syndrome. Fertil Steril 79 (2003) 469-481
11. Costello M.F., and Eden J.A. A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome. Fertil Steril 79 (2003) 1-13
12. Cataldo N.A., Abbasi F., McLaughlin T.L., Basina M., Fechner P.Y., Giudice L.C., et al. Metabolic and ovarian effects of rosiglitazone treatment for 12 weeks in insulin-resistant women with polycystic ovary syndrome. Hum Reprod 21 (2006) 109-120
13. Cataldo N.A., Abbasi F., McLaughlin T.L., Lamendola C., and Reaven G.M. Improvement in insulin sensitivity followed by ovulation and pregnancy in a woman with polycystic ovary syndrome who was treated with rosiglitazone. Fertil Steril 76 (2001) 1057-1059
14. Rautio K., Tapanainen J.S., Ruokonen A., and Morin-Papunen L.C. Endocrine and metabolic effects of rosiglitazone in overweight women with PCOS: a randomized placebo-controlled study. Hum Reprod 21 (2006) 1400-1407
15. Eisenhardt S., Schwarzmann N., Henschel V., Germeyer A., von Wolff M., Hamann A., et al. Early effects of metformin in women with polycystic ovary syndrome: a prospective randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 91 (2006) 946-952
16. Anderson R.A., Broadhurst C.L., Polansky M.M., Schmidt W.F., Khan A., Flanagan V.P., et al. Isolation and characterization of polyphenol type-A polymers from cinnamon with insulin-like biological activity. J Agric Food Chem 52 (2004) 65-70
17. Jarvill-Taylor K.J., Anderson R.A., and Graves D.J. A hydroxychalcone derived from cinnamon functions as a mimetic for insulin in 3T3-L1 adipocytes. J Am Coll Nutr 20 (2001) 327-336
18. Qin B., Nagasaki M., Ren M., Bajotto G., Oshida Y., and Sato Y. Cinnamon extract prevents the insulin resistance induced by a high-fructose diet. Horm Metab Res 36 (2004) 119-125
19. Qin B., Nagasaki M., Ren M., Bajotto G., Oshida Y., and Sato Y. Cinnamon extract (traditional herb) potentiates in vivo insulin-regulated glucose utilization via enhancing insulin signaling in rats. Diabetes Res Clin Pract 62 (2003) 139-148
20. Khan A., Safdar M., Ali Khan M.M., Khattak K.N., and Anderson R.A. Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care 26 (2003) 3215-3218
21. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
22. Katz A., Nambi S.S., Mather K., Baron A.D., Follmann D.A., Sullivan G., et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85 (2000) 2402-2410
23. Genuth S., Alberti K.G., Bennett P., Buse J., Defronzo R., Kahn R., et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26 (2003) 3160-3167
24. Matsuda M., and DeFronzo R.A. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22 (1999) 1462-1470